Mercado terapéutico y de diagnóstico de exosomas: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00005514
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 149
Buy Now

El mercado terapéutico y de diagnóstico de exosomas se valoró en 41,6,33 millones de dólares estadounidenses en 2019 y se espera que crezca a una tasa compuesta anual del 32,2 % entre 2020 y 2027 hasta alcanzar los 358,91 millones de dólares estadounidenses en 2027.

Los exosomas son nanovesículas que constituyen proteínas, ADN y ARN. Los exosomas desempeñan un papel importante a la hora de ayudar a la comunicación entre células durante el diagnóstico del cáncer. Disminuye la función inmune del cuerpo al estimular la muerte celular programada de las células T citotóxicas activadas, que modifican la progresión de las neoplasias dentro del cuerpo humano. Se espera que el mercado terapéutico y de diagnóstico de exosomas experimente un enorme crecimiento debido a una mayor precisión y ventajas sobre los métodos tradicionales de diagnóstico y terapéutica. Sin embargo, la infraestructura deficiente y la falta de experiencia necesaria para el aislamiento de exosomas pueden obstaculizar el crecimiento del mercado.

regiones lucrativas para el mercado terapéutico y de diagnóstico de exosomas


Perspectivas del mercado

Mayor precisión y ventajas sobre los métodos tradicionales de diagnóstico y terapéutica

Los exosomas son poblaciones distintas de pequeñas vesículas membranosas, liberadas en el espacio extracelular por la mayoría de las células, que eventualmente se acumulan en la circulación de fluidos corporales. Al actuar como mensajeros celulares, desempeñan un papel en funciones fisiológicas vitales al transportar información entre diferentes tipos de células. Estas pequeñas partículas transportan ácidos nucleicos y proteínas celulares desde sus células huésped a las células diana, que representan información completa sobre las condiciones fisiopatológicas de la célula huésped. Por ejemplo, los exosomas liberados de las células tumorales contienen ARN específicos de tumores que potencialmente pueden detectarse durante el diagnóstico del cáncer. Estos exosomas portadores también se pueden utilizar como biomarcadores en el diagnóstico de trastornos neurodegenerativos y metabólicos, así como de enfermedades infecciosas y de otro tipo. Además, es probable que la presencia de exosomas en fluidos corporales como la saliva y la orina descarte los métodos tradicionales que implican la recolección de fluidos corporales invasivos. Por lo tanto, es probable que el creciente énfasis en el diagnóstico clínico no invasivo impulse la adopción del diagnóstico basado en exosomas. y terapéutica en la industria médica durante el período de pronóstico.

Información basada en aplicaciones

Basado en la aplicación, el diagnóstico de exosomas y El mercado terapéutico se segmenta aún más en aplicaciones de diagnóstico y aplicaciones terapéuticas. El segmento de aplicaciones de diagnóstico tuvo una mayor participación del mercado en 2019 debido a la mayor conciencia de los resultados de los procedimientos que ofrecen los exosomas. Por ejemplo, en marzo de 2016, Sysmex y JVCKENWOOD lanzaron un programa conjunto para el desarrollo de instrumentos de diagnóstico para la medición de exosomas. Además, se espera que el segmento de diagnóstico registre una CAGR más alta en el mercado durante el período de pronóstico. Aparte de esto, los exosomas están surgiendo como plataformas terapéuticas prometedoras debido a su papel en la prolongación de enfermedades. Tal participación de los exosomas puede permitirnos inhibir la progresión de la enfermedad con la ayuda de una terapia farmacológica dirigida.

Mercado terapéutico y de diagnóstico de exosomas global, por aplicación: 2019 y 2019 2027


Información basada en productos

El mercado diagnóstico y terapéutico de exosomas, por producto, está sub segmentado en instrumentos, reactivos y software. En 2019, el segmento de instrumentos representó la mayor parte del mercado mundial de diagnóstico y terapéutico de exosomas debido a la creciente adopción de instrumentos para aplicaciones de diagnóstico. Sin embargo, se estima que el segmento de software registrará la CAGR más alta del mercado durante el período de previsión. Esto se puede atribuir a la demanda de plataformas tecnológicas que ofrezcan integridad, acceso y seguridad de los datos recopilados en aplicaciones terapéuticas y de diagnóstico de exosomas.

Información basada en el usuario final

El mercado terapéutico y de diagnóstico de exosomas, por usuario final, se segmenta aún más en institutos de cáncer, hospitales, centros de diagnóstico y otros. El segmento de institutos oncológicos tuvo la mayor participación del mercado en 2019 debido al aumento de los casos de cáncer y la demanda de enfoques de diagnóstico avanzados. El instituto del cáncer se dedica específicamente a la investigación del cáncer, el desarrollo de fármacos y el estudio sobre el tratamiento del cáncer. Se proyecta que la eficiencia de los exosomas en el diagnóstico del cáncer impulsará el crecimiento del segmento de institutos oncológicos durante el período de pronóstico.

Información estratégica

Las empresas suelen adoptar estrategias de expansión y lanzamiento de productos para expandir su presencia en todo el mundo y satisfacer la creciente demanda. Esta estrategia es adoptada más comúnmente por los actores del mercado para expandir su cartera de productos.

Los actores del mercado que operan en el mercado terapéutico y de diagnóstico de exosomas adoptaron la estrategia de innovación de productos para satisfacer la demanda cambiante de los clientes en todo el mundo. lo que también permite a los jugadores mantener su marca a nivel mundial.

Mercado terapéutico y de diagnóstico de exosomas: Por aplicación

  • Diagnóstico
  • Terapéutico


Mercado diagnóstico y terapéutico de exosomas: Por producto

  • Instrumentos
  • Reactivos
  • Software


Mercado diagnóstico y terapéutico de exosomas &ndash ; Por usuario final

  • Institutos oncológicos
  • Hospitales
  • Centros de diagnóstico
  • Otros

Mercado Diagnóstico y Terapéutico de Exosomas– Por geografía

  • América del Norte
    • Estados Unidos
    • Canadá
    • México
  • < li>Europa
    • Francia
    • Alemania
    • Italia
    • Reino Unido
    • España
    • Resto de Europa
  • Asia Pacífico(APAC)
    • China
    • India
    • Corea del Sur
    • Japón
    • Australia
    • Resto de APAC
  • Medio Oriente y Asia África (MEA)
    • Sudáfrica
    • Arabia Saudita
    • EAU
    • Resto de MEA
  • América del Sur (SAM)
    • Brasil
    • Argentina
    • Resto de SAM

Perfiles de la empresa

  • Aethlon Medical, Inc
  • Therapeutic Solutions International, Inc
  • ReNeuron Group plc
  • Immune Therapy Holdings AB
  • Cell Guidance Systems LLC
  • Ciencias bioregenerativas
  • Evomic Science LLC
  • NorgenBiotek Corp
  • Exosome Diagnostics, Inc./Bio-Techne
  • MiltenyiBiotec
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is e exosome diagnostic and therapeutic?

Exosome is nanovesicles that constitute proteins, DNA, and RNA. Exosomes play an important role in aiding cell-to-cell communication in the cancer diagnosis. It lowers the body's immune function by stimulating programmed cell death of activated cytotoxic T cells, which modifies neoplasm progression within the human body.

What are the driving factors for the exosome diagnostic and therapeutic market across the globe?

The factors that are driving growth of the market are greater precision and advantages over traditional methods of diagnosis and therapeutics and rise in research and development activities. Moreover, growing preference for noninvasive and novel diagnostic procedures are offering lucrative opportunities for the growth of the market.

Who are the major players in the exosome diagnostic and therapeutic market?

The exosome diagnostic and therapeutic market majorly consists of the players such as Aethlon Medical, Inc., Therapeutic Solutions International, Inc., ReNeuron Group plc, Immune Therapy Holdings AB, Cell Guidance Systems LLC, BioRegenerative Sciences, Evomic Science LLC, Norgen Biotek Corp., Exosome Diagnostics, Inc./Bio-Techne, and Miltenyi Biotec among others.

The List of Companies - Exosome Diagnostic and Treatment Market

  1. Aethlon Medical, Inc
  2. Therapeutic Solutions International, Inc
  3. ReNeuron Group plc
  4. Immune Therapy Holdings AB
  5. Cell Guidance Systems LLC
  6. BioRegenerative Sciences
  7. Evomic Science LLC
  8. Norgen Biotek Corp
  9. Exosome Diagnostics, Inc./Bio-Techne
  10. Miltenyi Biotech

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports